Your browser doesn't support javascript.
The effect of the COVID-19 pandemic on opioid prescribing for patients with pleuritic pain.
Ormsby, Andrew; Dietsche, Caitlin.
  • Ormsby A; Medical Student, University of Colorado School of Medicine, Denver, Colorado. ORCID: 0000-0002-6066-9959.
  • Dietsche C; Assistant Professor of Hospital Medicine, University of Colorado School of Medicine, Aurora, Colorado.
J Opioid Manag ; 18(6): 529-535, 2022.
Artículo en Inglés | MEDLINE | ID: covidwho-2202523
ABSTRACT

OBJECTIVE:

We sought to understand opioid prescribing for COVID-19 positive and negative patients with pleuritic pain during the first wave of the pandemic. We hypothesized that patients without COVID-19 would be prescribed opioids more frequently intrapandemic compared to prepandemic and postulated that COVID-19 patients would be prescribed opioids more frequently and at greater quantity than their peers.

DESIGN:

A retrospective observational analysis of electronic health record data.

SETTING:

A quaternary academic hospital from February through April 2020.

PARTICIPANTS:

A total of 1,400 of 3,169 adult inpatient hospitalizations involving pleuritic pain were included. MAIN

MEASURES:

Frequency and average daily dose of opioid prescriptions were analyzed using logistic and linear regression. Opioid prescribing habits were compared pre- and intrapandemic. Hypotheses and primary outcome measures were formulated prior to data collection. KEY

RESULTS:

During the pandemic, COVID-19 patients were 15.77 absolute percentage points less likely to be prescribed opioids compared to patients without COVID-19 (95 percent confidence interval (CI) -8.98 to -22.56 percent). Patients without COVID-19 were equally likely to be prescribed opioids pre- and intrapandemic (95 percent CI -9.37 to 2.42 percent). Odds ratio of opioid prescription for COVID-19 patients was 0.44 (95 percent CI 0.08-0.80). Within those given opioids, COVID-19 patients were prescribed 3.0 percent greater morphine milligram equivalents (MMEs) (95 percent CI 1.07-5.85 percent).

CONCLUSION:

During the first wave of the pandemic, COVID-19 patients with pleuritic pain were prescribed opioids less frequently than patients without COVID-19, while patients without COVID-19 were equally likely to be prescribed opioid pre- and intrapandemic. On the other hand, COVID-19 patients treated with opioids were given greater daily MMEs due to the greater utilization of opioid infusions.
Asunto(s)

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: COVID-19 / Analgésicos Opioides Tipo de estudio: Estudio experimental / Estudio observacional / Estudio pronóstico Tópicos: Covid persistente Límite: Adulto / Humanos Idioma: Inglés Revista: J Opioid Manag Asunto de la revista: Neurología / Psicofisiología / Terapia por drogas Año: 2022 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: COVID-19 / Analgésicos Opioides Tipo de estudio: Estudio experimental / Estudio observacional / Estudio pronóstico Tópicos: Covid persistente Límite: Adulto / Humanos Idioma: Inglés Revista: J Opioid Manag Asunto de la revista: Neurología / Psicofisiología / Terapia por drogas Año: 2022 Tipo del documento: Artículo